BioNTech SE (FRA:22UA)
Germany · Delayed Price · Currency is EUR 84.80
-0.75 (-0.88%)
At close: Sep 18, 2026
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of €21.04 billion as of September 18, 2026. Its market cap has increased by 5.68% in one year.
Market Cap
21.04B
Enterprise Value
7.94B
Revenue
2.65B
Ranking
n/a
PE Ratio
n/a
Stock Price
€84.80
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from 2.72B to 21.04B, an increase of 673.42%. That is a compound annual growth rate of 34.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 21.04B | 7.93% |
| Dec 31, 2025 | 19.50B | -26.11% |
| Dec 31, 2024 | 26.39B | 16.25% |
| Dec 29, 2023 | 22.70B | -33.55% |
| Dec 30, 2022 | 34.16B | -37.61% |
| Dec 31, 2021 | 54.75B | 241.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 56.46B |
| Bayer Aktiengesellschaft | 47.24B |
| Siemens Healthineers AG | 42.04B |
| Fresenius SE & Co. KGaA | 25.86B |
| Sartorius Aktiengesellschaft | 15.39B |
| Fresenius Medical Care AG | 10.25B |
| Ottobock SE & Co. KGaA | 3.55B |
| SCHOTT Pharma AG & Co. KGaA | 3.53B |